[Prevention in cardiovascular pathology]

Area of Science:

• Cardiology
• Public Health
• Preventive Medicine

Context:

• Cardiovascular risk assessment is crucial for managing arterial hypertension and hypercholesterolemia.
• Existing risk equations like Anderson's (Framingham) may not be suitable for all populations, necessitating localized risk estimation.
• Recommendations emphasize treatment decisions based on absolute cardiovascular risk, particularly for primary prevention.

Purpose:

• To highlight the importance of evaluating absolute cardiovascular risk in clinical practice for managing hypertension and hypercholesterolemia.
• To discuss the limitations of generic risk assessment tools and the need for population-specific models.
• To underscore the benefits of pharmacological interventions for hypertension and hypercholesterolemia, especially in high-risk individuals.

Summary:

• National and international guidelines advocate for cardiovascular risk assessment to guide treatment decisions for hypertension and hypercholesterolemia.
• While Anderson's equation is proposed, its applicability is limited, stressing the need for country-specific risk evaluations.
• The benefits of treating hypertension (beta-blockers, diuretics, ACE inhibitors, calcium antagonists) and hypercholesterolemia (statins) are well-established, with greater benefits observed at higher cardiovascular risk levels.
• Secondary prevention is effective, but the focus here is primary prevention, particularly for high-risk patients from an economic perspective.
• Informing the general population about cardiovascular risk factors and promoting patient education through healthcare networks are essential.

Impact:

• Emphasizes the need for tailored cardiovascular risk assessment tools for effective disease management.
• Reinforces the established benefits of pharmacological interventions in reducing cardiovascular events.
• Promotes a public health approach focused on patient education and awareness of cardiovascular risk factors.